Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study.
Hepatology
; 2024 Feb 15.
Article
en En
| MEDLINE
| ID: mdl-38358542
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Año:
2024
Tipo del documento:
Article